Fibulin‐2 and its association with fibrillin‐rich microfibrils in the papillary dermis of photoaged skin
暂无分享,去创建一个
[1] T. Krieg,et al. Increased deposition of fibulin‐2 in solar elastosis and its colocalization with elastic fibres , 2001, The British journal of dermatology.
[2] P. Steijlen,et al. A case of Rombo syndrome , 2001, The British journal of dermatology.
[3] R. Stern. The risk of melanoma in association with long-term exposure to PUVA. , 2001, Journal of the American Academy of Dermatology.
[4] J. Ring,et al. Toxische epidermale Nekrolyse (Arzneimittel-induziertes Lyell-Syndrom) - Teil 1: Klinik und Differentialdiagnose¹ - , 2001 .
[5] D. Heimbach,et al. Toxic epidermal necrolysis (TEN) in elderly patients. , 2001, The Journal of burn care & rehabilitation.
[6] G. Wasner,et al. Clinical picture: nail changes secondary to docetaxel. , 2001, Lancet.
[7] H. Chae,et al. Peroxiredoxin is ubiquitously expressed in rat skin: isotype-specific expression in the epidermis and hair follicle. , 2000, The Journal of investigative dermatology.
[8] A. Vanderkelen,et al. Immunoregulatory Effector Cells in Drug-Induced Toxic Epidermal Necrolysis , 2000, The American Journal of dermatopathology.
[9] M. de la Brassinne,et al. Subungual abscess: a new ungual side‐effect related to docetaxel therapy , 2000, The British journal of dermatology.
[10] V. Krčméry. Systemic chlorellosis, an emerging infection in humans caused by algae. , 2000, International journal of antimicrobial agents.
[11] Lawrence,et al. The long‐term results of cartilage removal alone for the treatment of chondrodermatitis nodularis , 1999, The British journal of dermatology.
[12] J. Polónia,et al. Nail Changes Secondary to Docetaxel (Taxotere) , 1999, Dermatology.
[13] C. Griffiths,et al. Fibrillin-rich microfibrils are reduced in photoaged skin. Distribution at the dermal-epidermal junction. , 1999, The Journal of investigative dermatology.
[14] G. Kao,et al. Disseminated cutaneous protothecosis in an immunocompromised host: a case report and literature review. , 1999, Cutis.
[15] T. Slaga,et al. Mechanism-based cancer prevention approaches: targets, examples, and the use of transgenic mice. , 1999, Journal of the National Cancer Institute.
[16] P. Haslett,et al. Thalidomide in toxic epidermal necrolysis , 1999, The Lancet.
[17] C. Brun-Buisson,et al. Randomised comparison of thalidomide versus placebo in toxic epidermal necrolysis , 1998, The Lancet.
[18] C. Jacob,et al. Nail bed dyschromia secondary to docetaxel therapy. , 1998, Archives of dermatology.
[19] S. Rhee,et al. Mammalian Peroxiredoxin Isoforms Can Reduce Hydrogen Peroxide Generated in Response to Growth Factors and Tumor Necrosis Factor-α* , 1998, The Journal of Biological Chemistry.
[20] S. Rhee,et al. Characterization of a Mammalian Peroxiredoxin That Contains One Conserved Cysteine* , 1998, The Journal of Biological Chemistry.
[21] M. Binder,et al. Onycholysis in patients treated with docetaxel. , 1998, Annals of oncology : official journal of the European Society for Medical Oncology.
[22] K. Jeang,et al. Regulatory Role for a Novel Human Thioredoxin Peroxidase in NF-κB Activation* , 1997, The Journal of Biological Chemistry.
[23] X. Pivot,et al. Docetaxel chemotherapy induces transverse superficial loss of the nail plate. , 1997, Archives of dermatology.
[24] N. Bräu,et al. Cutaneous protothecosis in a patient with AIDS and a severe functional neutrophil defect: successful therapy with amphotericin B. , 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[25] D. Y. Sanders,et al. Cutaneous protothecosis in association with the acquired immunodeficiency syndrome. , 1997, Southern medical journal.
[26] M. Song,et al. Docetaxel-induced subungual hemorrhage. , 1997, Dermatology.
[27] Y. Chae,et al. Successful treatment with fluconazole of protothecosis developing at the site of an intralesional corticosteroid injection , 1996, The British journal of dermatology.
[28] J. Roujeau,et al. Apoptosis as a mechanism of keratinocyte death in toxic epidermal necrolysis , 1996, The British journal of dermatology.
[29] E. Koestenblatt,et al. Cutaneous protothecosis and AIDS. , 1994, Journal of the American Academy of Dermatology.
[30] J. Uitto,et al. Enhanced elastin and fibrillin gene expression in chronically photodamaged skin. , 1994, The Journal of investigative dermatology.
[31] G. Church,et al. Cloning and sequencing of thiol-specific antioxidant from mammalian brain: alkyl hydroperoxide reductase and thiol-specific antioxidant define a large family of antioxidant enzymes. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[32] R. Stern,et al. The carcinogenic risk of treatments for severe psoriasis , 1994, Cancer.
[33] A. Vanderkelen,et al. Macrophages and tumor necrosis factor alpha in toxic epidermal necrolysis. , 1994, Archives of dermatology.
[34] J. Ferguson,et al. Narrow‐band (TL‐01) UVB air‐conditioned phototherapy for chronic severe adult atopic dermatitis , 1993, The British journal of dermatology.
[35] L. Kaufman,et al. Meningitis due to Prototheca wickerhamii in a patient with AIDS. , 1992, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[36] G. M. Ridder,et al. Age, sunlight, and facial skin: a histologic and quantitative study. , 1991, Journal of the American Academy of Dermatology.
[37] C. Lawrence. The treatment of chondrodermatitis nodularis with cartilage removal alone. , 1991, Archives of dermatology.
[38] J. Hawk,et al. The role of psoralen photochemotherapy (PUVA) in the treatment of severe atopic eczema in adolescents , 1988, The British journal of dermatology.
[39] I. Penn,et al. Cancers following cyclosporine therapy. , 1987, Transplantation proceedings.
[40] M. Beck. Treatment of chondrodermatitis nodularis helicis and conventional wisdom? , 1985, The British journal of dermatology.
[41] J. Parsons. Management of toxic epidermal necrolysis. , 1985, Cutis.
[42] P. Suthipinittharm,et al. Protothecosis: a report of two cases. , 1983, Mykosen.
[43] P. Westermark,et al. The Rombo syndrome: a familial disorder with vermiculate atrophoderma, milia, hypotrichosis, trichoepitheliomas, basal cell carcinomas and peripheral vasodilation with cyanosis. , 1981, Acta dermato-venereologica.
[44] R. Dobson,et al. British Association of Dermatologists , 2014 .
[45] T. R. Wade. Chondrodermatitis nodularis chronica helicis. A review with emphasis on steroid therapy. , 1979, Cutis.
[46] J. Parrish,et al. Oral psoralen photochemotherapy of atopic eczema , 1978, The British journal of dermatology.
[47] H. Sacks,et al. Cutaneous protothecosis in a patient receiving immunosuppressive therapy. , 1976, Archives of dermatology.
[48] R. Ross,et al. Elastic Fiber , 2020, Definitions.
[49] J. Gõmez Orbaneja,et al. [Toxic epidermal necrolysis]. , 1967, Revista clinica espanola.
[50] H. Spencer,et al. A CASE OF HUMAN PROTOTHECOSIS. , 1964, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[51] E. Davidson,et al. Alterations in human dermal connective tissue with age and chronic sun damage. , 1962, The Journal of investigative dermatology.